|
Erol Onel, M.D. is an experienced physician with strong clinical and academic background coupled with industry experience (all phases: 1, 2, 3a, 3b, and 4 in both large and small pharmaceutical companies) and corporate/market focus, who can bring leadership across therapeutic areas, speed drugs and devices to market, and expand product life-cycles.
Dr. Erol Onel’s current professional role.
Erol Onel, M.D. Senior Director, Medical Affairs (Pain, Post-Operative Care, Central Nervous System, Oncology)
- Provided scientific leadership to Research/Development and Established Product divisions
- Formulated strategic evaluations of internal and external product opportunities and clinical strategy
- Provided medical input to safety and pharmacovigilance groups
- Assisted in authorship multiple NDA submissions, clinical trial protocols, Investigator Brochures, and PSUR documents
- Oversaw multiple phase 3 clinical trials of 600-700 subjects; multiple phase 2 trials of 45-150; and multiple phase 1 trials of 16-100; completion ahead of schedule and under budget
- Expanded vendor environment to include national and international participation
Led national and international advisory board and CRO meetings
- Assisted in authorship of over 20 published posters, abstracts, and peer-reviewed papers
|